(Q3)Apr 30, 2022 | (Q2)Jan 31, 2022 | (Q1)Oct 31, 2021 | (FY)Jul 31, 2021 | (Q4)Jul 31, 2021 | (Q3)Apr 30, 2021 | (Q2)Jan 31, 2021 | (Q1)Oct 31, 2020 | (FY)Jul 31, 2020 | (Q4)Jul 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 66.06%-344.06K | -227.27%-658.86K | -1,388.49%-2.29M | -286.35%-2.28M | -429.13%-909.5K | -444.34%-1.01M | -16.20%-201.32K | -163.82%-154.15K | 7.53%-589.79K | 92.92%-171.89K |
Net income from continuing operations | -64.13%-5.42M | -552.18%-6.5M | -1,422.88%-9.23M | -2,932.10%-31.91M | -3,730.66%-27.01M | -670.20%-3.3M | -661.34%-997.17K | -829.11%-605.81K | 117.13%1.13M | 107.44%743.91K |
Operating gains losses | -86.40%839 | 103.09%3.45K | 1,099.27%23.12K | 84.82%-130.1K | 94.67%-26.57K | --6.17K | ---111.63K | --1.93K | -114.30%-857.1K | ---498.26K |
Depreciation and amortization | 3,681.20%285.75K | 4,323.58%334.29K | 4,254.72%329.09K | 827.96%280.51K | 4,128.87%257.83K | -6.04%7.56K | -6.05%7.56K | -6.05%7.56K | --30.23K | --6.1K |
Asset impairment expenditure | --0 | ---- | ---- | --8.91M | --8.91M | ---- | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | 300.48%1.78M | 116.80%70.21K | 187.49%367.67K | 1,897.81%898.91K | --443.79K | ---888.16K | ---417.91K |
Remuneration paid in stock | --3.76M | --4.03M | --6.16M | --5.22M | --3.13M | ---- | ---- | ---- | ---- | ---- |
Other non cashItems | 3,619.67%40.1K | 1,926.33%93.23K | -557.30%-36.88K | 156,444.21%13.76M | 32,005.16%13.75M | -98.44%1.08K | 40.55%-5.11K | 193.90%8.06K | --8.79K | ---43.11K |
Change In working capital | 645.26%990.16K | 408,138.53%1.33M | 14,345.15%459.69K | -1,639.78%-181.32K | 112.85%3.83K | -4,895.22%-181.6K | -103.95%-327 | -144.10%-3.23K | 80.10%-10.42K | -139.15%-29.8K |
-Change in receivables | -704.52%-219.23K | -3,401.80%-502.86K | --167.75K | ---652.11K | ---610.5K | ---27.25K | ---14.36K | --0 | --0 | --0 |
-Change in prepaid assets | 84.88%-26.79K | 611.37%476.54K | -1,349.47%-425.99K | -2,771.02%-695.91K | -911.21%-556.31K | -2,096.64%-177.2K | 316.73%66.99K | -604.53%-29.39K | 21.24%-24.24K | -874.08%-55.01K |
-Change in payables and accrued expense | 3,251.87%766.14K | 782.62%361.49K | -127.67%-7.24K | 8,343.91%1.17M | 4,542.05%1.17M | 549.23%22.86K | -578.50%-52.96K | 1,653.49%26.16K | 163.94%13.82K | 153.37%25.22K |
-Change in other current assets | --169.01K | --333.18K | --573.7K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Change in other working capital | --301.03K | --665.93K | --151.47K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 66.06%-344.06K | -217.11%-658.86K | -1,453.53%-2.29M | -286.35%-2.28M | -280.45%-909.5K | -751.49%-1.01M | -19.93%-207.77K | -152.77%-147.7K | 7.53%-589.79K | 90.16%-239.06K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 153.17%111.49K | 411.41K | -111.57K | -2,660.90%-1.23M | -217.04%-1.14M | -166.44%-209.68K | 97.48%-44.41K | -359.98K | ||
Net PPE purchase and sale | ---8.23K | ---11.25K | ---61.57K | ---1.99K | ---1.99K | ---- | ---- | ---- | --0 | ---- |
Net business purchase and sale | ---- | ---- | ---- | ---1.35M | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | 123.85%50K | ---- | ---- | 380.83%124.73K | 158.25%209.68K | -166.44%-209.68K | ---- | ---- | 97.31%-44.41K | ---359.98K |
Net other investing changes | --69.71K | --472.65K | ---50K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 153.17%111.49K | --411.41K | ---111.57K | -2,660.90%-1.23M | -217.04%-1.14M | -166.44%-209.68K | ---- | ---- | 97.48%-44.41K | ---359.98K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -168.35%-86.47K | -106.69%-303.18K | 2,766.56%235.96K | 11,428.28%4.28M | -2,807.33%-366.32K | 602.05%126.52K | 4.53M | -8.85K | -101.09%-37.8K | -1,260,100.00%-12.6K |
Net issuance payments of debt | -1,194.16%-116.47K | -3,213.04%-303.18K | -360.91%-40.79K | -615.10%-270.31K | -1,831.02%-243.31K | 64.29%-9K | ---9.15K | ---8.85K | ---37.8K | ---12.6K |
Net common stock issuance | ---- | ---- | ---- | --4.54M | ---135.52K | --135.52K | ---- | ---- | --0 | --0 |
Proceeds from stock option exercised by employees | --30K | --0 | --276.75K | --12.5K | --12.5K | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -168.35%-86.47K | -106.69%-303.18K | 2,766.56%235.96K | 11,428.28%4.28M | -2,807.33%-366.32K | 602.05%126.52K | --4.53M | ---8.85K | -101.09%-37.8K | -1,260,100.00%-12.6K |
Net cash flow | ||||||||||
Beginning cash position | -91.12%604.89K | -51.31%1.15M | 31.89%3.32M | -21.07%2.52M | 82.55%5.71M | 130.21%6.81M | -24.60%2.36M | -21.07%2.52M | 50.58%3.19M | -12.19%3.13M |
Current changes in cash | 70.91%-319.05K | -112.38%-550.63K | -1,286.25%-2.17M | 215.65%777.19K | -295.18%-2.42M | -740.26%-1.1M | 2,667.23%4.45M | -167.92%-156.55K | -162.73%-672.01K | 41.56%-611.64K |
Effect of exchange rate changes | --12.28K | --6.16K | ---402 | --25.62K | --25.62K | ---- | ---- | ---- | ---- | ---- |
End cash Position | -94.78%298.13K | -91.12%604.89K | -51.31%1.15M | 31.89%3.32M | 31.89%3.32M | 82.55%5.71M | 130.21%6.81M | -24.60%2.36M | -21.07%2.52M | -21.07%2.52M |
Free cash from | 65.25%-352.29K | -222.52%-670.11K | -1,495.22%-2.36M | -286.69%-2.28M | -281.28%-911.49K | -751.49%-1.01M | -19.93%-207.77K | -152.77%-147.7K | 7.53%-589.79K | 90.16%-239.06K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data